Topic: sales

Lab work

Vaccine scandal fallout in China hits Sinovac

U.S.-listed Sinovac Biotech said first-quarter earnings were hit by new rules on vaccine sales in China that came in response to a scandal unrelated to the company that involved the sale of poorly tracked vaccines through unlicensed vendors.
Sydney, Australia's business district.

High-flying Parnell dips on 2015 results and 2016 guidance

Last year, Aussie transplant Parnell Pharmaceuticals enjoyed strong demand in the U.S. for its products aimed at companion and food animals, driving its sales for the year up 58% to AU$13.2 million ($9.4 million), the company announced Feb. 24. It told investors to expect revenues to grow between 50% and 70% this year to at least $14 million.
Heart 1

Big Pharma's cardiovascular sales ain't what they used to be

Slumping sales for cardiovascular drugs isn't exactly a new phenomenon for Big Pharma, with some of the industry's top drugmakers facing lower numbers after recent patent expirations. But the trend continued in the same vein last year, with companies such as Novartis, Pfizer and Boehringer Ingelheim seeing the biggest drops in sales, and AstraZeneca and Sanofi also feeling the sting of declining revenues.


Celgene

Revlimid fuels Celgene sales rocket

Here's what one big drug can do: Celgene announced that it expects fiscal 2007 profits to double to $1.05 per share, as sales of its cancer drug